Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Asset disposition
Quarterly results
scPharmaceuticals Inc. (SCPH) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/10/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/10/2023 8-K Quarterly results
Docs: "scPharmaceuticals Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update"
06/08/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
06/07/2023 8-K Other Events  Interactive Data
05/10/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/10/2023 8-K Quarterly results
Docs: "scPharmaceuticals Inc. Reports First Quarter 2023 Financial Results and Provides Business Update"
04/27/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/27/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/22/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/22/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
03/22/2023 10-K Annual Report for the period ended December 31, 2022
03/22/2023 8-K Quarterly results
Docs: "scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update"
03/13/2023 SC 13G MILLENNIUM MANAGEMENT LLC reports a 5.1% stake in SCPHARMACEUTICALS INC.
03/10/2023 8-K Other Events  Interactive Data
02/27/2023 SC 13G Cowen Financial Products LLC reports a 7.1% stake in scPHarmaceuticals Inc.
02/14/2023 SC 13G/A 5AM Ventures IV, L.P. reports a 8% stake in scPharmaceuticals Inc.
02/14/2023 SC 13G ARMISTICE CAPITAL, LLC reports a 6.3% stake in SCPHARMACEUTICALS INC.
12/19/2022 8-K Quarterly results
11/29/2022 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
11/25/2022 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
11/23/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
11/23/2022 8-K Quarterly results
11/22/2022 FWP Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses:
11/21/2022 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
11/09/2022 10-Q Quarterly Report for the period ended September 30, 2022
11/09/2022 8-K Quarterly results
10/14/2022 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "Form of Warrant, issued by the Company to certain lenders, together with a schedule of warrant holders",
"Credit Agreement and Guaranty, by and among scPharmaceuticals Inc., the subsidiary guarantors from time to time party thereto, the lenders from time to time party thereto and Oaktree Fund Administration, LLC, as administrative agent"
08/15/2022 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
08/09/2022 10-Q Quarterly Report for the period ended June 30, 2022
08/09/2022 8-K Quarterly results
07/12/2022 8-K Quarterly results
06/15/2022 8-K Quarterly results
05/16/2022 10-Q Quarterly Report for the period ended March 31, 2022
05/16/2022 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy